Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Lacosamide Tablet and Syrup in Healthy Chinese Males
NCT03086382Phase 1Completed
- Sponsor
- UCB
- Start
- Feb 2017
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lacosamide in epilepsy (2 arms), sponsored by UCB. Primary endpoints: Maximum plasma concentration, Area under the plasma concentration-time curve from time zero to last quantifiable concentration and 1 more. Started Feb 2017; status: completed.
02
Drugs
lacosamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT03086382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03086382.